AWARDPURCHASE ORDERSmall business
Purchase order 75N95022P00016PINE PHARMACEUTICALS LLC
Overview
Award facts
- Net obligations
- $23.75K
- $23,754of $23.75K potential value
- Period of performance
- Dec 14, 2021 to May 2, 2025
- Ended
- Modifications
- 4
- Latest action May 2, 2025
- Contract type
- Purchase order
- PIID 75N95022P00016
Description of requirement
COMPOUNDING OF 10% POLYSORBATE-80 TO DILUTE TPM-001 INVESTIGATIONAL DRUG FOR TREATMENT OF PERITONEAL CANCER
Dates and value
- Award date
- Signed on Dec 14, 2021
- Potential end of performance
- May 1, 2025
- Current value
- $23,754Base and exercised options
- Potential value (if all options are exercised)
- $23,754
Obligations by fiscal year of action
- FY2022: $23,754
Total across 1 fiscal year: $23,754
Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded May 2, 2025. View on USAspending · Recipient on SAM.gov
Recipient
LocationTONAWANDA, NY
UEITCJXKNYD6WL5
CAGE code7JZE9
Business sizeSmall businessSize at award, per the contracting officer
Parent companyPINE PHARMACEUTICALS LLC
Business types and certifications
For-profit organizationLimited liability company
As represented in SAM.gov at the time of the action.
Subcontracting network
The prime, the subcontractors on this award, and their own subcontractors.
Agency and place
Awarding and funding
- Awarded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NIDA
- Funded by
- Department of Health and Human Services
- National Institutes Of Health
- NATIONAL INSTITUTES OF HEALTH NCATS
- Funded from
- National center for advancing translational sciences (0875)Program activities075-0875Federal accounts (agency financial reports)
Place of performance
- Place of performance
- Tonawanda, Erie County, New York 14150-5837
- Congressional district (place of performance)
- NY-26As reported at the time of the action
Classification and competition
Classification
- Product or service (PSC)
- 6505DRUGS AND BIOLOGICALS (product)
Competition
- Extent competed
- Not competed under SAPG
- Reason not competed
- SAP non-competition (FAR 13)SP2
- Solicitation procedures
- Simplified acquisitionSP1
- Set-aside
- No set-aside used
- Contract pricing
- Firm fixed priceJ
- Offers received
- 1
Solicitation and notices
- Solicitation ID
- 75N95022Q00007
- Solicitation date
- Nov 8, 2021
- Notices
- Combined Synopsis/Solicitation posted Nov 8, 2021
Contract details
- Subcontracting plan
- Plan not requiredB
- Commercial procedures
- Commercial products/servicesA
- Government-furnished property
- Transaction does not use GFE/GFPN
- Bundled requirement
- Not bundledH
- Consolidated requirement
- Not consolidatedD
- Undefinitized action (terms not final)
- No
Linked notices
Notice | Notice ID | Type | Link | Posted |
|---|---|---|---|---|
Transaction history
Modification history
- Base award
- Dec 14, 2021Base obligation at award: $26,557
- Latest action
- May 2, 2025 — Terminated for convenienceModification P00004
- Latest substantive action
- May 2, 2025 — Terminated for convenienceModification P00004
- Latest funding action
- Sep 20, 2022 — Funding onlyModification P00001; obligation change -$2,803; funding only: changes obligations, not scope
- Actions by type
- Base award1
- Supplemental agreement (within scope)2
- Funding only1
- Terminated for convenience1
Similar awards
PIID | Match | Awardee |
|---|---|---|
All contract data
All contract data
Every other field reported for this award, as of its latest reported action
Competition
- Evaluation preference
- No preference used
- Local area set-aside
- No
- Synopsized publicly (SAM.gov / FedBizOpps)
- Yes
- Simplified procedures for commercial items
- No
- A-76 (FAIR Act) action
- No
Pricing and financing
- Paid by purchase card
- No
Socio-economic and policy
- Recovered materials and sustainability
- No clauses included and no sustainability includedC
- EPA-designated product
- Not requiredE
- Clinger-Cohen Act planning (IT)
- No
Place and origin
- Domestic or foreign entity
- U.S. owned businessA
- Country of product or service origin
- United statesUSA
- Place of manufacture
- Mfg in U.S.D
Structure
- Award or IDV
- Award
- Award type
- Purchase orderB
- Awarding agency code
- 7500
- Awarding sub-tier code
- 7529
- Contracting office code
- 75N950
- Transactions recorded under this award key
- 5
Funding
- Funding agency code
- 7500
- Funding sub-tier code
- 7529
- Funding office code
- 75N95C
- Treasury accounts
- 075-2022/2022-0875-000
- Object classes
- 25.6: Medical care
- Disaster or emergency funding (DEFC)
- Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression